Andromeda Surgical Raises $15 Million Series A for Autonomous Surgery
Andromeda Surgical raised a $15 million Series A led by Standard Capital to commercialize an autonomous surgery platform starting in endourology.
HealthTech startup news from Silicon Valley, YC, and beyond: funding rounds, launches, and founders in digital health, biotech, and medical devices.
Andromeda Surgical raised a $15 million Series A led by Standard Capital to commercialize an autonomous surgery platform starting in endourology.
Healia raised a $14M Series A led by 111° West Capital, bringing its total funding to $18M, to expand a benefit that coordinates coverage across two employer health plans.
Assort Health has raised a $120M Series C led by Menlo Ventures, reaching a $1.2B valuation, to scale its AI agents platform across the patient journey.
Eli Lilly acquires YC-backed Engage Biologics and its Tethosome non-viral DNA delivery platform for up to $202 million in cash.
From programmable cancer drugs to AI primary care, here are the standout bio and healthtech companies from Y Combinator's Spring 2026 batch.
Founded by a Yale professor and his research partner, CellType is building AI agents and biological foundation models to replace slow, failure-prone drug development with computational simulations of human biology.
From parasite-derived autoimmune drugs to AI-powered fish farming, these are the bio and health companies to watch from YC's Winter 2026 batch.
Voice AI startup automates healthcare call centers with specialty-specific agents, bringing total funding to $102M in four months